Results 191 to 200 of about 5,857,342 (337)

A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndrome

British Journal of Haematology, EarlyView.
Fostamatinib had 46% durable response, with 73% steroid reduction, in this multicentre retrospective study of refractory wAIHA/ES. Hypertension, gastrointestinal (GI) distress and neutropenia occurred in 23%. Only one patient required drug discontinuation and one patient dose reduction.
Jorge N. Ruiz Lopez, Lipei Shao, Debbie Jiang, Lawrence S. Bailey, Thejaswi Bikkani, Aaron Boothby, Donald C. Moore, Irina Murakhovskaya, Caroline I. Piatek, Mauricio Pineda‐Roman, Ping Jin, Jacqueline N. Poston, Moritz Stolla, David F. Stroncek, Krystalyn E. Hudson, James B. Bussel, Sandhya R. Panch   +16 more
wiley   +1 more source

Effectiveness of Glucocorticoids in the No-Reflow Phenomenon in STEMI Patients

Український журнал серцево-судинної хірургії
Relevance. The driving force behind the pathogenesis of no-reflow, as a component of ischemic-reperfusion injury, is myocardial edema, which provokes extravascular compression of the infarct-related artery (IRA), making it impossible to restore antegrade
Maksim Y. Sokolov, Sergii V. Salo, Valentyn O. Shumakov, Serhii S. Shpak   +3 more
doaj  

Admission EASIX Score Predicts Coronary No-Reflow and In-Hospital Mortality in STEMI Patients Undergoing Primary PCI. [PDF]

J Clin Med
Şahin YB, Tanık VO, Boz S, Akdoğan M, Tunca Ç, Seçkin Ö, Taş A, Özlek B.   +7 more
europepmc   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Evidence on cardiovascular/renal outcomes associated with GLP‐1‐based therapies in type 1 diabetes (T1D) is limited. We examined the effects of GLP‐1‐based therapy on major clinical outcomes and safety, including diabetic ketoacidosis (DKA) and hypoglycemia risk, in adults with T1D in a large real‐world cohort.
Anastasios Tentolouris, Charalampos Filippatos, Nikolaos‐Iason Tepetes, Maria Gavriatopoulou, Evangelos Terpos, Alexandros Briasoulis, Kimon Stamatelopoulos, Theodosios Filippatos   +7 more
wiley   +1 more source

Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past. [PDF]

J Am Coll Cardiol, 2023
Dauerman HL.
europepmc   +1 more source

Harmonizing the paradigm with the data in stable coronary artery disease: A review and viewpoint [PDF]

, 2017
Brown, David L, Mitchell, Joshua D
core   +2 more sources

Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI.

JACC Cardiovascular Imaging, 2015
F. Saia, K. Komukai, D. Capodanno, V. Sirbu, G. Musumeci, G. Boccuzzi, G. Tarantini, M. Fineschi, G. Tumminello, C. Bernelli, G. Niccoli, M. Coccato, Barbara Bordoni, H. Bezerra, G. Biondi‐Zoccai, R. Virmani, G. Guagliumi   +16 more
semanticscholar   +1 more source

Oxygen‐independent expression of HIF‐1α during the cell cycle in hepatocellular carcinoma cells controls essential metabolic pathways under normoxia

The FEBS Journal, EarlyView.
In Huh7 cells, HIF‐1α is essential as it maintains the expression of proteins involved in glycolysis and steroid/cholesterol biosynthesis both under normoxia and hypoxia. On the other hand, in HeLa cells, these pathways are induced by HIF‐1α only under hypoxia.
Ioanna‐Maria Gkotinakou, Christina Arseni, Kreon Koukoulas, Martina Samiotaki, George Panayotou, George Simos, Ilias Mylonis   +6 more
wiley   +1 more source

Noninvasive assessment of right ventricular-pulmonary artery coupling may predict acute kidney injury after primary PCI in STEMI patients. [PDF]

BMC Cardiovasc Disord
Tiryaki MM, Nalbant A, Yılmaz C, Karaduman A, Gürsoy MO, Karaca M.   +5 more
europepmc   +1 more source

Myocardial Damage After Primary PCI

JACC: Cardiovascular Interventions, 2020
Sebastian Johannes Reinstadler, Bernhard Metzler   +1 more
openaire   +1 more source